AstraZeneca to Present Sample Collection Strategies at Biobanking 2013

LONDON - June 14, 2013 - PRLog -- SMi Group is pleased to announce that Douglas McKechnie, Biobank Operations Manager from AstraZeneca, will be presenting at this year’s Biobanking conference taking place soon on 24th – 25th June, London.

The new presentation will provide delegates with a unique insight on global biobank governance and the opportunity to discover sample collection strategies within Astra Zeneca.

The packed agenda also includes sessions from:

•          Julie Corfield, Director, Areteva  

•          Janine Swifka, Biobank Scientist, Bayer

•          Paul Whittaker, Director, Novartis

•          Shaun Griffin, Director of Communications, HRA & HTA

•          Kirstin Goldring, Biobank Facilitator, UCL Biobank

•          Ma’n H. Zawati, Academic Associate, Centre of Genomics and Policy, McGill University

The event now in its 3rd year is recognised as one of the industry’s leading events which focus on Biobanking strategies, ethics and innovation.

“The Smi Biobanking conference brings together key opinion leaders in the rapidly evolving field of biobanking. The ultimate success of biobanking will depend on overcoming both major technical and ethical challenges. The Biobanking conference will inform and guide our response to these challenges and will be provide an invaluable opportunity to understand and share best practice.” – Brian Thomson, Director of Research and Development, Nottingham University

For further information visit http://www.smi-online.co.uk/pharmaceuticals/uk/conference...